Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. (Q48341810)
Jump to navigation
Jump to search
scientific article published in January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. |
scientific article published in January 2007 |
Statements
1 reference
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. (English)
1 reference
Hans-Joachim Stemmler
1 reference
Manfred Schmitt
1 reference
Amina Willems
1 reference
Helga Bernhard
1 reference
Nadia Harbeck
1 reference
Volker Heinemann
1 reference
1 January 2007
1 reference
1 reference
18
1 reference
23-28
1 reference
1
1 reference
Identifiers
1 reference